# Correction: Novel probiotic Lactobacillus helveticus WIS02 alleviates diabetes through multi-pronged regulation of glycolipid metabolism, pancreatic protection and gut microbiota remodeling

**Authors:** Shuang Guo, Yuying Li, Yanan Yang, Yuexiao Jiang, Yufeng Wang, Ying Cao, Yunfeng Duan, Chongming Wu

PMC · DOI: 10.3389/fmicb.2026.1795126 · Frontiers in Microbiology · 2026-02-03

## Full-text entities

- **Diseases:** dyslipidemia (MESH:D050171), diabetes (MESH:D003920), DM (MESH:D009223)
- **Chemicals:** TC (MESH:D013667), STZ (MESH:D013311), glycolipid (MESH:D006017), LDL-C (-), TG (MESH:D013866), Glycerol (MESH:D005990)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Helicobacter cinaedi (species) [taxon 213], Lactobacillus helveticus (species) [taxon 1587], Homo sapiens (human, species) [taxon 9606], Bacteroides caecimuris (species) [taxon 1796613], Bacteroidia (class) [taxon 200643]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12910829/full.md

---
Source: https://tomesphere.com/paper/PMC12910829